Prihlásiť sa Zaregistrujte sa zadarmo

Predpokladaný rast EPS Q/Q spoločnosti Akari Therapeutics Plc

Aká je hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Akari Therapeutics Plc?

Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Akari Therapeutics Plc je -100.00%

Aká je definícia metriky Predpokladaný rast EPS Q/Q?



Očakávaný rast EPS (Estimated quarterly EPS growth rate) z roka na rok je predpokladaný rast EPS spoločnosti za ďaľší kvartál v porovnaní s výsledkami z minulého kvartálu.

The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

Predpokladaný rast EPS Q/Q spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Akari Therapeutics Plc

Čomu sa venuje spoločnosť Akari Therapeutics Plc?

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.

Firmy s metrikou predpokladaný rast eps q/q podobnou spoločnosti Akari Therapeutics Plc